icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025
 Back grey_arrow_rt.gif
 
 
 
Updated Early and Week 52 Biomarker (MRI-PDFF, ALT, MRE and PRO-C3) Responses to Resmetirom Associate With Improvements in MASH and Liver Fibrosis
 
 
  AASLD 2026 Denver

1108261copy

1108262copy

1108263copy

1108264copy

1108265copy

1108266copy

1108267copy

1108268copy

1108269copy

11082610 opy

11082611copy

11082612copy

11082613copy

11082614copy

11082615copy

11082616copy

11082617copy